Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gull Laboratories was a specialized medical diagnostics company that developed, manufactured, and marketed test kits for the detection of infectious diseases. The company was particularly well-known for its expertise in enzyme-linked immunosorbent assay (ELISA) and immunofluorescence assay (IFA) technologies. Its product portfolio focused on viral and bacterial infections, including Epstein-Barr virus, Lyme disease, and various herpesviruses. Headquartered in Salt Lake City, Utah, Gull Laboratories established a significant presence in the clinical laboratory market before being acquired by Meridian Diagnostics in 1998. The company's products were widely used in hospitals and commercial laboratories for the diagnosis of complex infectious conditions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gull Laboratories.